Harry Burn’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$145M Sell
3,673,882
-130,615
-3% -$4.67M 4.55% 1
2026
Q2
$129M Sell
3,804,497
-81,186
-2% -$2.7M 3.97% 1
2026
Q1
$117M Sell
3,885,683
-424,223
-10% -$13.6M 3.92% 1
2025
Q4
$135M Sell
4,309,906
-1,337,543
-24% -$33M 4.28% 2
2025
Q3
$114M Sell
5,647,449
-199,063
-3% -$3.5M 3.77% 1
2025
Q2
$98M Buy
5,846,512
+394,423
+7% +$6.36M 3.34% 7
2025
Q1
$83.8M Buy
5,452,089
+679,377
+14% +$12.1M 2.94% 16
2024
Q4
$105M Sell
4,772,712
-1,204,132
-20% -$21.9M 3.47% 3
2024
Q3
$108M Sell
5,976,844
-784,602
-12% -$13.7M 3.5% 2
2024
Q2
$110M Sell
6,761,446
-733,244
-10% -$11.3M 3.66% 1
2024
Q1
$106M Sell
7,494,690
-1,424,544
-16% -$18M 3.31% 7
2023
Q4
$93.1M Buy
8,919,234
+998,522
+13% +$9.32M 3.23% 8
2023
Q3
$80.8M Buy
+7,920,712
New +$73.8M 3.09% 9

Other funds holding TEVA

Harry Burn's TEVA Position: Q3 2026 in Review

Harry Burn reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 3.4% in Q3 2026, selling an estimated $4.67M and leaving 3,673,882 shares worth $145M. The position accounts for 4.55% of the portfolio, ranked #1.

Harry Burn first reported a position in TEVA in Q3 2023 and has held it in 13 quarters since. 477 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Harry Burn held 3,673,882 shares of Teva Pharmaceutical Industries Limited worth $145M as of Q3 2026.
  • Harry Burn sold 130,615 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $4.67M.
  • Teva Pharmaceutical Industries Limited made up 4.55% of Harry Burn's portfolio in Q3 2026, its #1 holding.
  • Harry Burn first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and has held it in 13 quarters since.
  • 477 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Sound Shore Management's 13F filing for Q3 2026, filed 6 Nov 2026.